FIELD: medicine.
SUBSTANCE: method involves administering Corbiculin at a dose of 2 g three times a day when prediluted with 50 ml of water. The treatment course is 21 days long or longer until alanine aminotransferase and aspartate aminotransferase indices assume normal values.
EFFECT: enhanced effectiveness in normalizing hyperenzymemia and relieving clinic manifestations of cytolytic syndrome.
2 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| AGENT "EXTRAHOLM" FOR SUGAR CONTROL IN PATIENTS SUFFERING FROM DIABETES COMPLICATED BY HEPATOPATHY AND BILE PASSAGES DISORDERS | 2007 | 
 | RU2360695C1 | 
| METHOD OF COMPLEX TREATMENT OF CHRONIC VIRAL HEPATITISIS TYPES B AND C | 2007 | 
 | RU2341275C1 | 
| METHOD OF TREATMENT OF LIVER DISEASES | 2006 | 
 | RU2334499C2 | 
| METHOD FOR SELECTION OF MEDICINAL PREPARATIONS FOR TREATMENT OF PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2002 | 
 | RU2221243C1 | 
| MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 | 
 | RU2419449C1 | 
| METHOD OF TREATING PATIENTS WITH HEPATIC CIRRHOSIS | 2012 | 
 | RU2509566C1 | 
| METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 | 
 | RU2286792C1 | 
| METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH APPLICATION OF DALARGIN MAGNETOPHORESIS | 2011 | 
 | RU2473325C1 | 
| METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 | 
 | RU2348412C1 | 
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 | 
 | RU2519198C2 | 
Authors
Dates
2006-05-10—Published
2004-05-19—Filed